All Articles

ToonieBet's new partnership with the Hamilton Tiger-Cats is not just a sponsorship. It's a calculated move in Ontario's $66B iGaming arena. Here's why.

Australian radiopharma innovator AdvanCell is planting its flag in Greater Boston with a new HQ and factory, a strategic move to scale its potent Lead-212 therapy.

bioAffinity Technologies' new gene-silencing therapy kills common skin cancer cells in lab studies while leaving healthy cells untouched, hinting at a future without scars.

Chinese innovator Kandi Technologies is aggressively expanding its off-road vehicle business, a strategic pivot that bets on deep localization over pure volume.

With 1 in 4 seniors facing isolation, Element Care is using a $100K grant to prove that belonging is a clinical imperative, not just a 'nice-to-have'.

Veea Inc. bolsters its leadership to capture the booming edge AI market, but can seasoned executives overcome daunting financial hurdles and fierce competition?

A CAD$40M military contract validates NorthStar's space tech, bolsters Canada's sovereignty, and fuels its high-stakes journey to the public market.

GuideAI Health's new AI software, which scans for peripheral vascular disease, promises to slash diagnosis times and prevent amputations for millions.

Fish & Richardson's new AI tool isn't just about efficiency. It's a look at how secure, in-house AI is reshaping the very foundation of patent law.

A looming Azure Maps price shock forces a critical choice: absorb a massive cost increase or navigate a complex migration. The deadline is closer than you think.

As Prime Day looms, a new survey reveals a deep split. Younger shoppers embrace AI and deals, while older consumers remain skeptical. What does this mean for retail?

As Saint-Jean-Baptiste Day nears, MADD Canada's plea reveals a deeper issue: Quebec's outlier status on a road safety policy proven to save lives and money.

Beyond the finish line, VCARB and Salesforce are building an 'Agentic Enterprise,' using AI not just for speed, but for permanent fan connection and operational strength.

Doosan Robotics' new AI solutions promise unprecedented efficiency. But beyond the demos, a deeper look reveals the challenges of skill gaps and the true cost of an automated future.

Upexi's debt-for-equity deal shores up its balance sheet but raises questions about dilution and the high-risk strategy behind its massive Solana treasury.

How the 75-year-old denim icon is weaving its authentic heritage into the fabric of modern country music through a strategic, nationwide festival tour.

Masimo's FDA-cleared AI monitor for opioid risk does more than track vitals; it predicts danger, pushing healthcare from reactive alarms to proactive intervention.

As work moves to the browser, so do the threats. Cybersecurity firm MirrorTab hires Colin Britton to scale its 'isolation' tech for a new reality.

Genius Group's massive share repurchase program aims to boost shareholder value, but a look at its financials reveals a high-stakes gamble. Is this a confident bet or a red flag?

From my desk in The Engine Room, I analyze the blueprint behind Thirsty Buddha's bold leap from Canada into Costco UK and LA. This is more than a drink launch.